Paper468786
Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations.
Adachi K and 1 other. J Biol Chem, 1979. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations. Papers, record 468786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/468786
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemoglobin, Sickle | Major topic |
| Humans | |
| Kinetics | |
| Osmolar Concentration | |
| Protein Binding | |
| Spectrophotometry | |
| Temperature |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39920120 | Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease. | Nat Commun | 2025 | https://conductscience.org/library/papers/39920120 | PubMed |
| 34510823 | Caffeic acid: an antioxidant with novel antisickling properties. | FEBS Open Bio | 2021 | https://conductscience.org/library/papers/34510823 | PubMed |
| 33661300 | MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease. | Blood Adv | 2021 | https://conductscience.org/library/papers/33661300 | PubMed |
| 30630954 | Substitutions in the β subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30630954 | PubMed |
| 28770911 | Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects. | Metallomics | 2017 | https://conductscience.org/library/papers/28770911 | PubMed |
| 26187468 | Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26187468 | PubMed |
| 17493634 | Metastable polymerization of sickle hemoglobin in droplets. | J Mol Biol | 2007 | https://conductscience.org/library/papers/17493634 | PubMed |
| 17350155 | The role of beta93 Cys in the inhibition of Hb S fiber formation. | Biophys Chem | 2007 | https://conductscience.org/library/papers/17350155 | PubMed |
| 17131194 | Pair-wise interactions of polymerization inhibitory contact site mutations of hemoglobin-S. | Protein J | 2006 | https://conductscience.org/library/papers/17131194 | PubMed |
| 16819835 | Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide. | Biochemistry | 2006 | https://conductscience.org/library/papers/16819835 | PubMed |
| 15465861 | Aggregation of normal and sickle hemoglobin in high concentration phosphate buffer. | Biophys J | 2004 | https://conductscience.org/library/papers/15465861 | PubMed |
| 12124399 | A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12124399 | PubMed |
| 10827998 | Solubility of fluoromethemoglobin S: effect of phosphate and temperature on polymerization. | Biophys J | 2000 | https://conductscience.org/library/papers/10827998 | PubMed |
| 10096916 | Sickle hemoglobin polymer melting in high concentration phosphate buffer. | Biophys J | 1999 | https://conductscience.org/library/papers/10096916 | PubMed |
| 9172771 | Solubility of sickle hemoglobin measured by a kinetic micromethod. | Biophys J | 1996 | https://conductscience.org/library/papers/9172771 | PubMed |
| 7937904 | Recombinant human hemoglobins designed for gene therapy of sickle cell disease. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7937904 | PubMed |
| 7670370 | Mutational analysis of phenylalanine beta 85 in the valine beta 6 acceptor pocket during hemoglobin S polymerization. | Protein Sci | 1995 | https://conductscience.org/library/papers/7670370 | PubMed |
| 6498276 | Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. | Biophys J | 1984 | https://conductscience.org/library/papers/6498276 | PubMed |
| 6256747 | Proton longitudinal relaxation investigation of histidyl residues of normal human adult and sickle deoxyhemoglobin: evidence for the existence of pregelation aggregates in sickle deoxyhemoglobin solutions. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6256747 | PubMed |
| 3242632 | Kinetics of domain formation by sickle hemoglobin polymers. | Biophys J | 1988 | https://conductscience.org/library/papers/3242632 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/468786
GET https://conductscience.org/api/papers/v1/468786/cited_by?page=2